Administration of STING ligands inhibits tumor growth and potentiates the antitumor effects of radiation and immune checkpoint blockade through the production of IFN-I (Deng et al, 2014; Demaria et al, 2015; Temizoz et al, 2015). This evidence concerns the gene STING1 and neoplasm.